Literature DB >> 22796192

H3K27 methylation and H3S28 phosphorylation-dependent transcriptional regulation by INHAT subunit SET/TAF-Iβ.

Ji-Young Kim1, Kee-Beom Kim, Hye-Ju Son, Yun-Cheol Chae, Si-Taek Oh, Dong-Wook Kim, Jhang Ho Pak, Sang-Beom Seo.   

Abstract

Significant progress has been made in understanding the relationship between histone modifications and 'reader' molecules and their effects on transcriptional regulation. A previously identified INHAT complex subunit, SET/TAF-Iβ, binds to histones and inhibits histone acetylation. To investigate the binding specificities of SET/TAF-Iβ to various histone modifications, we employed modified histone tail peptide array analyses. SET/TAF-Iβ strongly recognized PRC2-mediated H3K27me1/2/3; however, the bindings were completely disrupted by H3S28 phosphorylation. We have demonstrated that SET/TAF-Iβ is sequentially recruited to the target gene promoter ATF3 after the PRC2 complex via H3K27me recognition and may offer additive effects in the repression of the target gene.
Copyright © 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22796192     DOI: 10.1016/j.febslet.2012.06.026

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  ZRANB1 Is an EZH2 Deubiquitinase and a Potential Therapeutic Target in Breast Cancer.

Authors:  Peijing Zhang; Zhenna Xiao; Shouyu Wang; Mutian Zhang; Yongkun Wei; Qinglei Hang; Jongchan Kim; Fan Yao; Cristian Rodriguez-Aguayo; Baochau N Ton; Minjung Lee; Yumeng Wang; Zhicheng Zhou; Liyong Zeng; Xiaoyu Hu; Sarah E Lawhon; Ashley N Siverly; Xiaohua Su; Jia Li; Xiaoping Xie; Xuhong Cheng; Liang-Chiu Liu; Hui-Wen Chang; Shu-Fen Chiang; Gabriel Lopez-Berestein; Anil K Sood; Junjie Chen; M James You; Shao-Cong Sun; Han Liang; Yun Huang; Xianbin Yang; Deqiang Sun; Yutong Sun; Mien-Chie Hung; Li Ma
Journal:  Cell Rep       Date:  2018-04-17       Impact factor: 9.423

Review 2.  The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes.

Authors:  Alison Urvalek; Kristian Bruun Laursen; Lorraine J Gudas
Journal:  Subcell Biochem       Date:  2014

Review 3.  Priming chromatin for segregation: functional roles of mitotic histone modifications.

Authors:  M Lienhard Schmitz; Jonathan M G Higgins; Markus Seibert
Journal:  Cell Cycle       Date:  2020-01-28       Impact factor: 4.534

Review 4.  Regulation of PP2A by Sphingolipid Metabolism and Signaling.

Authors:  Joshua Oaks; Besim Ogretmen
Journal:  Front Oncol       Date:  2015-01-15       Impact factor: 6.244

5.  CDK1-mediated phosphorylation at H2B serine 6 is required for mitotic chromosome segregation.

Authors:  Markus Seibert; Marcus Krüger; Nikolaus A Watson; Onur Sen; John R Daum; Johan A Slotman; Thomas Braun; Adriaan B Houtsmuller; Gary J Gorbsky; Ralf Jacob; Michael Kracht; Jonathan M G Higgins; M Lienhard Schmitz
Journal:  J Cell Biol       Date:  2019-02-14       Impact factor: 10.539

6.  MSK-Mediated Phosphorylation of Histone H3 Ser28 Couples MAPK Signalling with Early Gene Induction and Cardiac Hypertrophy.

Authors:  Emma L Robinson; Faye M Drawnel; Saher Mehdi; Caroline R Archer; Wei Liu; Hanneke Okkenhaug; Kanar Alkass; Jan Magnus Aronsen; Chandan K Nagaraju; Ivar Sjaastad; Karin R Sipido; Olaf Bergmann; J Simon C Arthur; Xin Wang; H Llewelyn Roderick
Journal:  Cells       Date:  2022-02-09       Impact factor: 6.600

7.  LHX3 interacts with inhibitor of histone acetyltransferase complex subunits LANP and TAF-1β to modulate pituitary gene regulation.

Authors:  Chad S Hunter; Raleigh E Malik; Frank A Witzmann; Simon J Rhodes
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

Review 8.  NUP214 in Leukemia: It's More than Transport.

Authors:  Adélia Mendes; Birthe Fahrenkrog
Journal:  Cells       Date:  2019-01-21       Impact factor: 6.600

9.  PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen.

Authors:  Samantha L Tinsley; Brittany L Allen-Petersen
Journal:  NAR Cancer       Date:  2022-02-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.